- Consumer Products
- Latest 95.09
- Currency US$
- Change 0.39
- Percent Change 0.412 %
- Volume 963,194
- Fri Aug 29, 2014 11:40 AM EDT NASDAQ data delayed 15 minutes.
12 months ended Mar 31, 2014.
Trailing 12 month results shown above.
All data is in U.S. dollars.
|Earnings||Jul 24||$0.77||Oct 23||$0.82|
12 months ended Aug 29, 2014.
A look at major corporate events and financial announcements that are coming up.
About the Company
Celgene Corp. is an independent biopharmaceutical company engaged primarily in the discovery, development and commercialization of orally administered, small molecule drugs for the treatment of cancer and immunological diseases.